Jan 7, 2025 · The Company is developing broad-spectrum nanoviricides to combat several diseases: NV-387 combats RSV, COVID-19, Flu and Smallpox; NV-HHV-1 combats Shingles …

NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections.

Get the latest NanoViricides, Inc. (NNVC) stock news and headlines to help you in your trading and investing decisions.

NanoViricides, Inc. is a global leader in the development of nanomedicine drugs against viruses. Our unique nanoviricide® platform technology defines a novel mechanism enabling first-in …

NanoViricides, Inc. is a globally leading company in the application of nanomedicine technologies to the complex issues of viral diseases. The nanoviricide® technology enables direct attacks …

SHELTON, CT / ACCESSWIRE / April 30, 2024 / NanoViricides, Inc. (NYSE Amer: NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, reports that the …

5 days ago · NanoViricides, Inc. is a clinical stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add …

Feb 12, 2025 · NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections.

Feb 10, 2025 · NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections.

Dec 22, 2024 · Discover real-time NanoViricides, Inc. Common Stock (NNVC) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay …